225 related articles for article (PubMed ID: 30978640)
1. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.
Lin HI; Cheng YC; Ko HW; Wen CH; Lu HE; Huang CY; Hsieh PCH; Lin CH
Stem Cell Res; 2019 May; 37():101447. PubMed ID: 31029016
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations.
Chiu CC; Wang HL; Weng YH; Chen RS; Chen CM; Yeh TH; Lu CS; Chen YJ; Liu YC; Huang YZ; Chang KH
Stem Cell Res; 2019 Oct; 40():101552. PubMed ID: 31493761
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
5. Development of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient carrying the N551K variant in LRRK2 gene.
Ma D; Ng EY; Zeng L; Lim CY; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():51-53. PubMed ID: 28395804
[TBL] [Abstract][Full Text] [Related]
6. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
7. Derivation of human induced pluripotent stem cell (iPSC) line with LRRK2 gene R1398H variant in Parkinson's disease.
Ma D; Tio M; Ng SH; Li Zeng ; Lim CY; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():48-50. PubMed ID: 28395803
[TBL] [Abstract][Full Text] [Related]
8. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL
Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174
[TBL] [Abstract][Full Text] [Related]
9. GENYOi004-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with autism-related ADNP syndrome carrying a pTyr719* mutation.
Montes R; Mollinedo P; Perales S; Gonzalez-Lamuño D; Ramos-Mejía V; Fernandez-Luna JL; Real PJ
Stem Cell Res; 2019 May; 37():101446. PubMed ID: 31035039
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cell line LNDWCHi001-A from a patient with early-onset Parkinson's disease carrying the homozygous c.1898C > T (p. A633V) mutation in the PLA2G6 gene.
Huang J; Jiang Q; Pang D; Yu Y; Cui Y; Li C; Shang H
Stem Cell Res; 2024 Mar; 75():103305. PubMed ID: 38215561
[TBL] [Abstract][Full Text] [Related]
11. A human induced pluripotent stem cell line (TRNDi007-B) from an infantile onset Pompe patient carrying p.R854X mutation in the GAA gene.
Cheng YS; Li R; Baskfield A; Beers J; Zou J; Liu C; Zheng W
Stem Cell Res; 2019 May; 37():101435. PubMed ID: 31026687
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
Chu YT; Lin HY; Chen PL; Lin CH
BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
[TBL] [Abstract][Full Text] [Related]
13. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
14. Generation of feeder-independent transgene-free iPSC lines from a young-onset Parkinson's disease (YOPD) patient with a homozygous PLA2G6: c.2222G>A (p. Arg741Gln) mutation (NCBSi003-A) and unaffected heterozygous parent (NCBSi004-A).
Gopurappilly R; Musthafa T; Sukumaran S; Viswanath B; Hasan G
Stem Cell Res; 2023 Mar; 67():103033. PubMed ID: 36706537
[TBL] [Abstract][Full Text] [Related]
15. Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene.
Baskfield A; Li R; Beers J; Zou J; Liu C; Zheng W
Stem Cell Res; 2019 May; 37():101436. PubMed ID: 31009819
[TBL] [Abstract][Full Text] [Related]
16. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
[TBL] [Abstract][Full Text] [Related]
17. An induced pluripotent stem cell line (TRNDi006-A) from a MPS IIIB patient carrying homozygous mutation of p.Glu153Lys in the NAGLU gene.
Huang W; Xu M; Li R; Baskfield A; Kouznetsova J; Beers J; Zou J; Liu C; Zheng W
Stem Cell Res; 2019 May; 37():101427. PubMed ID: 30933722
[TBL] [Abstract][Full Text] [Related]
18. Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling.
Ke M; Chong CM; Zeng H; Huang M; Huang Z; Zhang K; Cen X; Lu JH; Yao X; Qin D; Su H
Cell Death Dis; 2020 Feb; 11(2):130. PubMed ID: 32071291
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene.
Lopez-Onieva L; Montes R; Lamolda M; Romero T; Ayllon V; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
Stem Cell Res; 2016 May; 16(3):692-5. PubMed ID: 27346198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
